The present invention is directed to novel 3,4-diamino-3-cyclobutene-1,2-dione derivatives, pharmaceutical compositions containing them and their use in the treatment of disorders related to potassium channel.
Edits on 19 May, 2023
"Remove website redirecting to Patent Public Search front page"